Excess cardiovascular deaths in the beginning of COVID-19 outbreak
Preprint
Abstract
Importance: The healthcare demand created by the COVID-19 pandemic was far beyond the hospital surge capacity in many countries, resulting in possible negative influence on prognosis of other severe diseases, such as cardiovascular disease (CVD). Objective: To assess the impact of the COVID-19 outbreak on CVD-related hospitalizations and mortality. Design: Community-based prospective cohort study. Setting the UK Biobank population. Participants: 421,717 UK Biobank participants who were registered in England and alive on December 1 st 2019. Main outcomes and measures: The primary outcome of interest was CVD death, as deaths with CVD as a cause of death according to the death registers. We retrieved information on hospitalizations with CVD as the primary diagnosis based on the UK Biobank hospital inpatient data. The study period was between December 1 st 2019 and May 30 th 2020, and we used the same calendar period of the three preceding years as the reference period. Standardized mortality/incidence ratios (SMRs/SIRs) with 95% confidence intervals were used to estimate the relative risk of CVD outcomes during the study period, compared with the reference period, to control for seasonal variations and aging of the study population. Results: We observed a distinct increase in CVD-related deaths in March and April 2020 as compared to the corresponding months of the three preceding years. The observed number of CVD death (n=217) was almost doubled in April, compared with the expected number (n=120), corresponding to an SMR of 1.81 (95% CI 1.58-2.06). We observed a sharp decline of CVD hospitalization in March (n=841) and April (n=454), compared with the expected number (n=1208 for March and 1026 for April), leading to an SIR of 0.70 (95% CI 0.65-0.74) for March and 0.44 (95% CI 0.40-0.48) for April. There was also a clear increase of death, but a clear decrease of hospitalization, in March and April for all the five major subtypes of CVD. Conclusions: We observed a distinct excess in CVD deaths in the beginning of the COVID-19 outbreak in the UK Biobank population. In addition to CVD complications of SARS-CoV-2 infections, the reduced hospital capacity might have contributed to the observed excess CVD deaths. Key Points: Question: How did the COVID-19 outbreak affect rates of CVD-related death and hospitalization? Finding: In this prospective study involving 421,717 UK Biobank participants, we observed excess CVD-related mortality in parallel with decreased CVD-related hospitalization in the beginning of the COVID-19 pandemic, March and April 2020. Meaning: In addition to severe SARS-CoV-2 infection progressing to CVD-related death, reduced hospital resources might have partially contributed to the excess CVD mortality.Keywords
All Related Versions
- Published version: BMJ Open, 11 (6), e046931.
This publication has 6 references indexed in Scilit:
- Excess Deaths From COVID-19 and Other Causes, March-April 2020JAMA, 2020
- The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysisProgress in Cardiovascular Diseases, 2020
- Advances in the relationship between coronavirus infection and cardiovascular diseasesBiomedicine & Pharmacotherapy, 2020
- Potential Effects of Coronaviruses on the Cardiovascular SystemJAMA Cardiology, 2020
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, ChinaJAMA Cardiology, 2020
- Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort studyBMJ, 2019